Avid Bioservices Inc (CDMO)
10.49
+0.22
(+2.14%)
USD |
NASDAQ |
Nov 04, 13:08
Avid Bioservices Enterprise Value: 775.66M for Nov. 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 775.66M |
| October 31, 2024 | 755.89M |
| October 30, 2024 | 768.01M |
| October 29, 2024 | 769.92M |
| October 28, 2024 | 764.82M |
| October 25, 2024 | 758.44M |
| October 24, 2024 | 771.83M |
| October 23, 2024 | 781.40M |
| October 22, 2024 | 785.87M |
| October 21, 2024 | 760.99M |
| October 18, 2024 | 768.01M |
| October 17, 2024 | 768.01M |
| October 16, 2024 | 771.20M |
| October 15, 2024 | 775.66M |
| October 14, 2024 | 766.73M |
| October 11, 2024 | 778.85M |
| October 10, 2024 | 769.28M |
| October 09, 2024 | 781.40M |
| October 08, 2024 | 780.77M |
| October 07, 2024 | 789.06M |
| October 04, 2024 | 798.63M |
| October 03, 2024 | 794.16M |
| October 02, 2024 | 805.65M |
| October 01, 2024 | 821.59M |
| September 30, 2024 | 846.47M |
| Date | Value |
|---|---|
| September 27, 2024 | 843.92M |
| September 26, 2024 | 833.08M |
| September 25, 2024 | 805.01M |
| September 24, 2024 | 861.15M |
| September 23, 2024 | 829.89M |
| September 20, 2024 | 860.51M |
| September 19, 2024 | 914.74M |
| September 18, 2024 | 849.03M |
| September 17, 2024 | 853.49M |
| September 16, 2024 | 840.73M |
| September 13, 2024 | 832.44M |
| September 12, 2024 | 832.44M |
| September 11, 2024 | 796.71M |
| September 10, 2024 | 789.70M |
| September 09, 2024 | 691.45M |
| September 06, 2024 | 683.80M |
| September 05, 2024 | 694.64M |
| September 04, 2024 | 709.95M |
| September 03, 2024 | 741.21M |
| August 30, 2024 | 792.89M |
| August 29, 2024 | 781.40M |
| August 28, 2024 | 772.47M |
| August 27, 2024 | 776.94M |
| August 26, 2024 | 781.40M |
| August 23, 2024 | 795.44M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
147.23M
Minimum
Mar 20 2020
2.079B
Maximum
Nov 05 2021
862.23M
Average
854.72M
Median
Aug 19 2024
Enterprise Value Benchmarks
| MEI Pharma Inc | -17.89M |
| Altimmune Inc | 314.11M |
| NovaBay Pharmaceuticals Inc | 3.615M |
| Palatin Technologies Inc | 13.93M |
| iBio Inc | 9.837M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.534M |
| Revenue (Quarterly) | 40.17M |
| Total Expenses (Quarterly) | 42.63M |
| EPS Diluted (Quarterly) | -0.09 |
| Gross Profit Margin (Quarterly) | 14.22% |
| Profit Margin (Quarterly) | -13.78% |
| Earnings Yield | -21.64% |
| Normalized Earnings Yield | -21.64 |